Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
CAR-T Cells infusion（CAR2219,CAR2019, CAR19 etc）
Locations
1
China
TianJin China. TianJin Medical University General
Tianjin, Tianjin Municipality, China
Start Date
November 9, 2024
Primary Completion Date
February 28, 2026
Completion Date
February 28, 2027
Last Updated
April 4, 2025
NCT06859424
NCT05091372
NCT07347171
NCT04268199
NCT07236021
NCT05932680
Lead Sponsor
Tianjin Medical University General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions